Delivery Order SPE2DR25D3103-SPE2DR26F9X05
- Not listed
- The Defense Logistics Agency awarded a $12,047.87 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, meaning the award was made through full and open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a $2,936.87 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Durolane 60 mg/3 ml syringes. This non-set-aside, competitively awarded contract reflects a firm fixed-price transaction with an ultimate completion date of January 9, 2026, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order operates as a child contract under Cencora, Inc., the parent pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes valued at $7,568.71, with an ultimate completion date of November 13, 2025. This contract was awarded on a firm fixed-price basis without set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,495.41 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's significantly...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,233.45 for Durolane 60 mg/3 mL syringes on January 5, 2026, with completion expected by January 6, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,931.14 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 30, 2025, with performance completion targeted for December 31, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12.7K under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X05Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,791.84 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on January 13, 2026, with an ultimate completion date of January 14, 2026. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., a major pharmaceutical distribution and healthcare solutions provider. This delivery order is issued under Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 31, 2031. The IDC serves as a global pharmaceutical support vehicle enabling supply of a comprehensive range of medications, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. Durolane, a hyaluronic acid-based intra-articular injection commonly used for osteoarthritis treatment, represents a specialized medical commodity within the broader scope of the contract's therapeutic coverage.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 1/12/26 |